Use of Dashmool trivrita tail uttarbasti in udavrutta yonivyapad ( Dysmenorrhea)as a painkiller

Single Arm Clinical study to assess the Analgesic Effect of Dashmoola Trivrita Tail Uttarbasti in Udavrutta Yonivyapada( Dysmenorrhea)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/02/049611

Enrollment

Registered

2023-02-10

Start date

Unknown

Completion date

Unknown

Last updated

2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N945- Secondary dysmenorrhea

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Sexually active women. - Pratyatma lakshana (kashtartava) of Udavrutta Yonivyapada. -Primary Dysmenorrhea -Secondary Dysmenorrhea- Adenomyosis, endometriosis - Age between 18 to 40 yrs. -People who will be ready to follow instructions.

Exclusion criteria

Exclusion criteria: Leucorrhea -PID -k/c/oMalignancy -Menorrhagia - Uterine fibroids -IUCD in utero -Cervical stenosis -Congenital uterine anomalies -Patient who were not ready to give consent.

Design outcomes

Primary

Measure	Time frame
To evaluate the analgesic effect of Dashmoola Trivrita tail Uttarbasti in Udavrutta Yonivyapada ( Dysmenorrhea)Timepoint: follow up will be taken each 1 month for 3 consecutive cycles.	—

Secondary

Measure	Time frame
To evaluate the analgesic effect of Dashmoola Trivrita tail Uttarbasti in Udavrutta Yonivyapada ( Dysmenorrhea)Timepoint: follow up will be taken each month for 3 consecutive cycles.	—

Countries

India

Contacts

Public ContactDR DURGESHWARI RAUT

YMT Ayurvedic Medical College and Hospital Sector 4, Kharghar, Navi Mumbai

seema.mehre@gmail.com9930940403

Outcome results